Kenya could be safer than many countries when it comes to HIV drug resistance, thanks to its reliance on tenofovir-based regimens.A new study has found that resistance to dolutegravir (DTG), the ...

The WHO approves lenacapavir every six months as a new step in HIV prevention, simplifying diagnoses and expanding ...

This release is being retransmitted for extra exposure to downstream sites. SHELTON, CT / ACCESS Newswire / September 11, ...

It’s the first update since an initial list was published a decade ago, in 2015. Since then, new threats have emerged, ...

Scientists at Merck & Co. have unveiled the structure of the company’s latest candidate for HIV pre-exposure prophylaxis ...

Kenya could be safer than many countries when it comes to HIV drug resistance, thanks to its reliance on tenofovir-based ...

K8 was found to reduce geographic atrophy lesion area growth by more than 50% in its first human clinical trial of the drug.

New Alzheimer’s drugs known as anti-amyloid therapies may slow disease progression—but they also carry serious risks, ...

Andrew Oakes told Newsweek he wanted to die after the diagnosis because it was like a dirty secret and people called him reckless.

Opioids, including the best known—morphine, heroin and fentanyl—have been gaining popularity over the last few decades.

Merck offers a compelling opportunity for long-term income and value investors, trading near its 52-week low with a 4% dividend yield. Learn more about MRK stock here.